NovoCure Limited
NVCRNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $1.70B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $9.82$21.45
- Volume (live)
- -
- Avg. volume (3M)
- 1.43M
NovoCure (NVCR) Stock Price & Financial Analysis
NovoCure Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $14.53 - $14.97 |
|---|---|
| 52-Week High | $21.45 |
| 52-Week Low | $9.82 |
| Open | $14.85 |
| Volume (last close) | 1.13M |
| Average Volume (3M) | 1.43M |
| Revenue (TTM) | 699.19M |
|---|---|
| Net Income (TTM) | -148.56M |
| Free Cash Flow (TTM) | -25.43M |
| EPS (TTM) | −$1.31 |
| Profit Margin | -21.25% |
| Operating Margin | -22.08% |
| Return on Equity (ROE) | -43.94% |
| Debt to Equity | 0.58 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.70B |
|---|---|
| Shares Outstanding | 116.01M |
| Price to Sales (P/S) | 2.44 |
| Price to Book (P/B) | 5.04 |
| EV/EBITDA | -17.91 |
| 50-Day MA | $16.30 |
|---|---|
| 200-Day MA | $14.81 |
| 1-Year Change | +8.48% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
NovoCure at a Glance
As of the Oct 23, 2026 close, NovoCure (NVCR) has a market capitalization of $1.70B. The stock trades at 2.4× sales. Over the trailing twelve months it lost $148.56M on revenue of $699.19M and burned $25.43M of free cash flow. Revenue grew 10.9% year over year.
As of its latest reported balance sheet, it holds $93.70M in cash and securities against $195.89M of debt, a net debt position of $102.19M.
NovoCure does not currently pay a dividend.
The share price is up 8.5% over the past year. At $14.68 (the Oct 23, 2026 close) it sits within its 52-week range of $9.82 to $21.45, below its 200-day moving average of $14.81.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About NovoCure
What is the current stock price for NVCR?
As of the Oct 23, 2026 close, NVCR stock trades at $14.68. The 52-week range is $9.82–$21.45, with a day range of $14.53–$14.97.
What is the P/E ratio for NVCR?
The P/E ratio (Price-to-Earnings) for NVCR is shown in the Key Statistics section. This valuation metric helps compare NovoCure Limited to industry peers.
Does NVCR pay dividends?
NovoCure does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NVCR?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for NVCR is Buy.
What is the market cap of NVCR?
As of the Oct 23, 2026 close, NovoCure's market capitalization is $1.70B, classifying it as a small-cap company. NovoCure operates in the Healthcare sector within the Medical Devices industry.